• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

OMF- Reflections from London and Denmark (by Chris Armstrong, PhD)

Ben H

OMF Volunteer Correspondent
Messages
1,131
Location
U.K.
Hi guys,

Tocq_jpLnd-dCvxKHzsxwmvp0QJ_hAFqJKB1Bl-Ek0kLzjzQyBcJCsus1E99yTjkwYjs67JX6_9RcOfHiwuQhHKrn6PD6Yc5o4nZlkbVA7NkfKNwws0ueEF_tsZrtL2nREnorGCgOzFGBQlxZtwZJp7oha3vAh4Xf0UZeyVnJNj1NN_zTKflEXYlkGEgyshDBEpSvpk8hbPaiWA=s0-d-e1-ft

Reflections on the IiME Conference Week 2019
Written by Christopher Armstrong, PhD, OMF Science Liaison

This was possibly the largest ME/CFS meeting I had ever been to, which indicates how fast the research field is growing. There were 4 days of talks from before 9am until after 6pm every day and the talks were kept to around 20 minutes each.
It began on Tuesday the 28th of May with the young investigator conference coined
“Thinking the Future”, an initiative started at the Invest in ME conference last year and elaborated upon at the NIH meeting just a couple of months ago. I was pleasantly surprised by the number of PhD students and the depth of their presentations. We discussed the paths to take for a future career in ME/CFS, the methods we could use to maintain momentum and how to keep the young investigators encouraged to move forward. Many young investigators commented that patient engagement was a strong source of positive experiences for them, so I would like to openly acknowledge and thank those patients that contact researchers the world over. The mutual benefits of researcher-patient interaction are truly remarkable.

The colloquium was spanned over two days, Wednesday and Thursday. Researchers from around the world presented their most recent findings. Each talk had a unique perspective and many were quite thought-provoking. The audience was very engaged, with very few empty seats and plenty of questions. Every session seemed to run overtime, which was a good indication of the amount of work there was to discuss. Each of the breaks and dinners were filled with excited chatter and possibilities. This colloquium has a particularly relaxed feel which provides a comfortable environment for collaboration building between scientists and clinicians.

The final day was primarily for the patients, the talks provided insight into the larger project being undertaken in the field and provided evidence that progress is happening all around.

klNdg52nTjYHl6zLKtN-EWJMKAv3XDsUAPxz7mLAxB-PfpLc7PhlMGOVA3LO_kAfXmvQVM_qo1EtNVYBKddkwD2YKV3-horijtcG38AIpWCmd7gUAfwrVF06SpBj-bk_FHu8R6_fgOg=s0-d-e1-ft

Left to right: Dr. Ron Davis; Linda Tannenbaum; Dr. Chris Armstrong & Linda;
Ron Davis, Maureen Hanson & Dr. Ronald Tompkins

The day began with a rallying cry from Dr Ian Gibson leading into two presentations from the major government research entities from the United States, the CDC and NIH represented, by Dr Elizabeth Unger and Vicky Whittemore respectively.

Over the day there were several talks by OMF Scientific Advisory Board (SAB) members, including Dr. Maureen Hanson discussing the “Immune Dysregulation in ME/CFS” and Dr. Øystein Fluge updating us on “Rituximab in ME/CFS: a randomized, double-blind and placebo-controlled trial”.

SAB Director and leader of the Collaborative Research Center at Stanford, Dr. Ron Davis, outlined an array of projects that are “Establishing new mechanistic and diagnostic paradigms for ME/CFS”. He began by detailing the main outcomes from the Severely ill Patients Study before launching into discussing the various diagnostic technology being developed and finally ending with the metabolic trap hypothesis.

SAB and co-leader of the Collaborative Research Activities at Harvard, Dr. Ron Tompkins, previewed the “Harvard Plans for Clinical Research into ME/CFS”. He highlighted the muscle biopsy study to characterize post-muscular stress in ME/CFS, this is in collaboration with Nottingham University (UK). Dr. Tompkins also gave an overview of the clinical work flow underway at Harvard, bringing several silos of research together to form a collaborative unit. One such researcher working within this collaboration is Dr. Michael VanElzakker, he discussed his brain imaging work.

During the breaks, many patients, carers and scientists surrounded the table that OMF had set up. They discussed their thoughts on the research being presented and wanted to know more about future directions. It was wonderful to interact with the broader community in an open way. Invest in ME once again delivered a tremendous platform for the sharing of research data and ideas. The researchers all felt very inspired and energized by these several days in London.

XbnuILYXIUEHKpX0tfotDhf0Um4coPXwRD18seE2B_OEXGsuoZJKw8RRKIoNiTHKuBzTcxgW76JtiSEEuhwXVwTX0p0Am1cIRI15z4-obfqncjcABOPZKG7VUb1TURftwQ=s0-d-e1-ft

Left to right back row: Wenzhong Xiao, Daniel Peterson;
Front row: Jonas Bergquist, Linda Tannenbaum, Ron Davis, Øystein Fluge,
Maureen Hanson, Ron Tompkins, Chris Armstrong

Visiting our friends in Denmark
Written by Linda Tannenbaum, OMF Founder & CEO/President

After our meetings in London, I continued on my End ME/CFS Worldwide Tour 2019 with a stop in Copenhagen, Denmark on Sunday, June 2nd. It was very important for me to be in Denmark and shine an international light on the many challenges Danish patients are facing, and show them the USA, OMF and the world care, and understand their challenges.

Upon my arrival, I was welcomed by Helle Florgaard (Board Member) and her husband and Cathrine Engsig (Vice-Chair) from the Danish ME Association/ME Foreningen. At my talk, there were about 40 attendees including the chairman of The Swedish National Association for ME Patients (RME), Kerstin Heiling, who came all the way from Sweden. Most of the attendees were patients and caregivers. We had a lot of engagement and many questions. At the personal meet and greet afterward, I had the pleasure to talk to some patients; their personal stories keep touching my heart.

Rzwd9ZDM0NVGc7qlmH_0UhGq7dMmQCl1bg58LUfEqM5zOjR_44dFA3QqYfFLHqCmzefqnbTGG-bim1Jo2yPep1_DIKFAVsiE2y7EGeBpDVRndyVHKJ0KX67T8-lgb_V7lOs9JlRq=s0-d-e1-ft

Left to Right: Left: Vibeke Vind (Scientific Consultant Danish ME Association), Linda Christensen (Board Member Danish ME Association) Linda Tannenbaum and Cathrine Engsig (Vice-Chair).
Picture middle: Linda and Cathrine; Picture right: Vibeke, Cathrine, Linda.

It was not only important for me to give an update on what OMF is doing to accelerate open collaborative research to unravel ME/CFS, but I also wanted to raise awareness, share information and especially bring hope to Danish patients. The people were very nice and thanked us all for spreading hope.

“It was lovely to have Linda come all the way to Denmark and bring hope and research updates,” according to Cathrine Engsig. “The situation in Denmark for ME patients is not good. Although the parliament has decided that ME is a somatic disease and should be treated as one, the Danish doctors don’t agree with the politicians and are angry that this happened. They don’t have much knowledge about ME. Doctors don’t recognize the disease and only one private doctor is known to give the diagnosis in Denmark due to the heavy influence of psychiatry on the government level."

In London, I already had the honor of meeting with Dr. Jesper Mehlsen. Dr. Mehlsen is seeing patients and doing research in Denmark and we look forward to collaborating with him. Dr. Mehlsen is a very caring doctor; he understands the disease, sees many patients and treats their symptoms.

After the meeting, we all had a nice dinner together with several members of the Danish ME Association, where we talked about the ME/CFS situation in Denmark and exchanged hope and ideas to conquer this terrible disease together. We especially want to thank our new friends from the Danish ME Association, in particular, Rebecca Hansen (Chair), Cathrine and Helle for their warm welcome and a perfectly organized event! We truly hope that with these Worldwide Tour talksand blogs – we can offer some hope and much needed scientific information so that health authorities will better understand this terrible disease.


Father's Day is quickly approaching.
Shop for Dad on Amazon Smile and support OMF. (US only)



www.omf.ngo



B,​
 

Inara

Senior Member
Messages
455
SAB Director and leader of the Collaborative Research Center at Stanford, Dr. Ron Davis, outlined an array of projects that are “Establishing new mechanistic and diagnostic paradigms for ME/CFS”.
Does someone know what kind of projects that are, and what is meant by "mechanistic paradigms for ME/CFS"?